In a phase III trial of adults with type 2 diabetes with heart disease and/or chronic kidney disease, oral semaglutide ...

China's National Health Commission (NHC) published its first set of guidelines to standardise the diagnosis and treatment of ...

He was inspired to become a doctor and research clinician by his father, a math teacher who was very scientifically oriented.

Adverse birth outcomes further increased the risk of disturbances with feeding in childhood and infancy (HR 4.53, 95% CI 2.97 ...

China's National Health Commission has released its first set of guidelines aimed at standardizing the diagnosis and ...

China's National Health Commission has introduced new guidelines to combat the rising obesity rates, with over half its ...

Reducing childhood and teenage obesity could save more than $7 billion in lifetime costs, but decision makers are ...

When will it bend the curve on obesity?

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...